AI Science Tracker
EN

Department of Automation, School of Information Science and Engineering, East China University of Science and Technology, Shanghai, China

1 discovery from 2021

Discoveries

Automatic Pancreatic Ductal Adenocarcinoma Detection in Whole Slide Images Using Deep Convolutional Neural Networks

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The tested patch-level classification accuracy was 95.33%; whole-slide detection/segmentation results were also reported.

Technology: A deep convolutional network classified and segmented pancreatic ductal adenocarcinoma whole-slide histopathology images.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A deep convolutional network classified and segmented pancreatic ductal adenocarcinoma whole-slide histopathology images.
Limitation / still unknown
Pathologist-confirmed 60 normal and 171 cancer samples with test evaluation; performance does not establish clinical workflow or external generalization.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full#s2 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full#s3–s4 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.665929/full#s2–s4 · https://pubmed.ncbi.nlm.nih.gov/34249702/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.